150 related articles for article (PubMed ID: 7837727)
1. [Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis].
Tomono K
Kekkaku; 1994 Nov; 69(11):725-32. PubMed ID: 7837727
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
Mizutani S
Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
[TBL] [Abstract][Full Text] [Related]
4. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
5. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Yamamoto M; Kuze F; Sakatani M; Saito H; Shimoide H; Soejima R; Hara K
Kekkaku; 1997 Jan; 72(1):1-7. PubMed ID: 9038009
[TBL] [Abstract][Full Text] [Related]
6. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
[TBL] [Abstract][Full Text] [Related]
7. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections].
Kawahara S; Nagare H
Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
[TBL] [Abstract][Full Text] [Related]
9. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
10. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
11. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
Mizutani S
Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
[TBL] [Abstract][Full Text] [Related]
12. [Chemoprophylaxis against Mycobacterium avium complex infection induced in mice].
Saito H; Murakami K; Kobayashi K; Gidoh M; Hidaka T; Kwon HH
Kekkaku; 1999 Sep; 74(9):677-81. PubMed ID: 10535281
[TBL] [Abstract][Full Text] [Related]
13. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
14. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Sato K; Ebe T
Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
[TBL] [Abstract][Full Text] [Related]
15. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection].
Kurashima A
Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Dautzenberg B; Saint Marc T; Meyohas MC; Eliaszewitch M; Haniez F; Rogues AM; De Wit S; Cotte L; Chauvin JP; Grosset J
Arch Intern Med; 1993 Feb; 153(3):368-72. PubMed ID: 8427539
[TBL] [Abstract][Full Text] [Related]
17. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
Tomioka H; Saito H
Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K
Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of nontuberculous mycobacterial (NTM) disease.
Griffith DE; Wallace RJ
Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
